Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Magnetic Resonance Cholangio Pancreatography | Case report

Type IV choledochal cyst with polycystic kidney disease: a case report

Authors: Yuxin He, Zhuwen Yu, Weichang Chen

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

Choledochal cysts are divided into 5 types. Physicians believe that Caroli disease (which refers to type V biliary cysts) is a special type of biliary cyst caused by a mutation in the PKHD1 gene and is associated with autosomal recessive polycystic kidney disease (ARPKD). There is currently no clear association between other types of choledochal cysts and polycystic kidney disease.

Case presentation

We report a 65-year-old male patient with jaundice, decreased appetite, and itchy skin. His biochemistry test results indicated obstructive jaundice disease. Cross-sectional imaging showed a type IVA choledochal cyst accompanied by autosomal dominant polycystic kidney disease (ADPKD). Due to economic difficulties, the patient achieved percutaneous transhepatic cholangial drainage (PTCD) instead of surgery.

Conclusion

To our knowledge, this is the second case report of the coexistence of type IVA choledochal cysts and ADPKD. We conclude that it is vital to be aware that the above condition is a possibility. This case report will aid earlier diagnosis and management and possibly prevent further damage to liver and kidney function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alonso-Lej F, Rever WB, Pessagno DJ. Congenital choledochal cyst, with a report of 2, and an analysis of 94, cases. Int Abstr Surg. 1959;108:1.PubMed Alonso-Lej F, Rever WB, Pessagno DJ. Congenital choledochal cyst, with a report of 2, and an analysis of 94, cases. Int Abstr Surg. 1959;108:1.PubMed
2.
go back to reference Todani T, Watanabe Y, Narusue M, et al. Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg. 1977;134(2):263–9.CrossRef Todani T, Watanabe Y, Narusue M, et al. Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg. 1977;134(2):263–9.CrossRef
3.
go back to reference Kerckhove LD, Meyer MD, Verbaandert C, et al. The place of liver transplantation in Caroli's disease and syndrome. Transpl Int. 2010;19(5):381–8.CrossRef Kerckhove LD, Meyer MD, Verbaandert C, et al. The place of liver transplantation in Caroli's disease and syndrome. Transpl Int. 2010;19(5):381–8.CrossRef
4.
go back to reference Pei Y, Obaji J, Dupuis A, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20(1):205–12.CrossRef Pei Y, Obaji J, Dupuis A, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20(1):205–12.CrossRef
5.
go back to reference Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrol. 2018;29(1):13–23.CrossRef Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrol. 2018;29(1):13–23.CrossRef
6.
go back to reference European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77(6):881–94.CrossRef European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77(6):881–94.CrossRef
7.
go back to reference Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272(5266):1339–42.CrossRef Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272(5266):1339–42.CrossRef
8.
go back to reference Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919–35.CrossRef Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919–35.CrossRef
9.
go back to reference Porath B, Gainullin VG, Cornec-Le Gall E, et al. Mutations in GANAB, encoding the Glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 2016;98(6):1193–207.CrossRef Porath B, Gainullin VG, Cornec-Le Gall E, et al. Mutations in GANAB, encoding the Glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 2016;98(6):1193–207.CrossRef
10.
go back to reference Besse W, Dong K, Choi J, et al. Isolated polycystic liver disease genes define effectors of polycystin-1 function. J Clin Invest. 2017;127(5):1772–85. Besse W, Dong K, Choi J, et al. Isolated polycystic liver disease genes define effectors of polycystin-1 function. J Clin Invest. 2017;127(5):1772–85.
11.
go back to reference Babbitt DP. Congenital choledochal cysts: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann Radiol. 1969;12(3):231–40.PubMed Babbitt DP. Congenital choledochal cysts: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann Radiol. 1969;12(3):231–40.PubMed
12.
go back to reference Peake JM, Gerrard DF, Griffin JFT, et al. The presence of a positive pressure gradient from pancreatic duct to Choledochal cyst demonstrated by Duodenoscopic microtransducer Manometry: clue to Pancreaticobiliary reflux. Endoscopy. 1982;14(02):45–7.CrossRef Peake JM, Gerrard DF, Griffin JFT, et al. The presence of a positive pressure gradient from pancreatic duct to Choledochal cyst demonstrated by Duodenoscopic microtransducer Manometry: clue to Pancreaticobiliary reflux. Endoscopy. 1982;14(02):45–7.CrossRef
13.
go back to reference Ishibashi H, Shimada M, Yada K. Japanese clinical practice guidelines for congenital biliary dilatation. J Hepato-Biliary-Pancreatic Sci. 2017;24(1):2004. Ishibashi H, Shimada M, Yada K. Japanese clinical practice guidelines for congenital biliary dilatation. J Hepato-Biliary-Pancreatic Sci. 2017;24(1):2004.
14.
go back to reference Ward CJ, Hogan MC, Rossetti S, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet. 2002;30(3):259–69.CrossRef Ward CJ, Hogan MC, Rossetti S, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet. 2002;30(3):259–69.CrossRef
15.
go back to reference Masyuk TV, Huang BQ, Ward CJ, et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology. 2003;125(5):1303–10.CrossRef Masyuk TV, Huang BQ, Ward CJ, et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology. 2003;125(5):1303–10.CrossRef
16.
go back to reference Philips CA, Kalal CR, Sahney A. Combined type IV a and type III choledochal cysts associated with autosomal dominant polycystic kidney disease in an adult. Int J Adv Med. 2017;2(2):163.CrossRef Philips CA, Kalal CR, Sahney A. Combined type IV a and type III choledochal cysts associated with autosomal dominant polycystic kidney disease in an adult. Int J Adv Med. 2017;2(2):163.CrossRef
17.
go back to reference Urribarri AD, Munoz-Garrido P, Perugorria MJ, et al. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases. Gut. 2014;63(10):1658–67.CrossRef Urribarri AD, Munoz-Garrido P, Perugorria MJ, et al. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases. Gut. 2014;63(10):1658–67.CrossRef
18.
go back to reference Onori P, Mancinelli R, Franchitto A, et al. Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease. Liver Int. 2013;33(6):914–25.CrossRef Onori P, Mancinelli R, Franchitto A, et al. Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease. Liver Int. 2013;33(6):914–25.CrossRef
Metadata
Title
Type IV choledochal cyst with polycystic kidney disease: a case report
Authors
Yuxin He
Zhuwen Yu
Weichang Chen
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01445-2

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine